| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.16 | 0.002 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.15 | 0.002 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.004 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | 0.092 | 0.005 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | -0.087 | 0.005 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | -0.087 | 0.006 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.14 | 0.006 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.14 | 0.008 |